LAIR1 and neoplasm: The effect of the anti-Lair1 antibody on NAS T cells followed a similar trend but to a much lesser extent in terms of T cell–tumor interactions and tumor inhibition, likely due to the lack of antigen specificity (Supplemental Figure 8, A–E, and Supplemental Videos 3 and 4).